BETA Technologies Q2 2026: Revenue Surges to $14.7M, Full-Year Guidance Raised
BETA sits 81% above its 52-week low of $13.43.
Summary
BETA Technologies reported Q2 2026 revenue of $14.7 million, up 146% year-over-year, and raised its full-year revenue outlook to $42–$50 million. Net loss widened to $148.8 million amid surging R&D costs, while the company held $1.48 billion in cash.
Key Events · Earnings and Guidance · BETA
-
Q2 Revenue More Than Doubles
Revenue reached $14.7 million in Q2 2026, up from $6.0 million in Q2 2025, driven by $11.4 million in service revenue and $3.3 million in product revenue.
-
Full-Year Revenue Guidance Raised
BETA increased its 2026 revenue guidance to $42–$50 million, up from a prior implied range, reflecting growing commercial and defense order momentum.
-
Net Loss Widens on R&D Surge
Net loss expanded to $148.8 million from $80.4 million a year ago, as R&D expenses more than doubled to $122.4 million, including $16.1 million in IPR&D and $5.7 million in non-cash warrant expense.
-
Adjusted EBITDA Loss Guidance Updated
Full-year 2026 Adjusted EBITDA loss is now expected to be between $400 million and $445 million, reflecting continued heavy investment in certification and infrastructure.
Analysis · BETA · Manufacturing
BETA's Q2 revenue more than doubled year-over-year to $14.7 million, driven by service revenue growth and early product deliveries. The company raised its full-year 2026 revenue guidance to $42–$50 million, signaling confidence in its commercial and defense pipeline. However, net losses widened to $148.8 million as R&D spending nearly doubled, reflecting heavy investment in certification and new aircraft programs. With $1.48 billion in cash, BETA has ample runway to fund operations through its growth phase, but the escalating cash burn and updated Adjusted EBITDA loss guidance of up to $445 million underscore the capital-intensive nature of its aerospace ambitions.
At the time of this filing, BETA was trading at $24.29 on NYSE in the Manufacturing sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $13.43 to $39.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.